From bioelectronic medicines that treat chronic diseases, to brain computer interfaces that help stroke rehabilitation, neurotechnology will play an increasingly important role in meeting some of the challenges of an ageing society. The UK already has a world leading research base in neurotechnology. The Neurotechnology Special Interest Group will help transfer knowledge from academia to the fast-growing industry sector and will provide a vital meeting place between clinicians and technologists. The aims of the SIG are to grow the neurotechnology community and accelerate innovation through cross-sector collaborations.
If you want to know more about the SIG, please contact Charlie Winkworth-Smith, Knowledge Transfer Manager, Emerging Technologies.